Date Posted: 07/30/2025
Closing Date: 09/03/2025, 11:59PM ET
Req ID: 44420
Job Category: Faculty - Clinical
Faculty/Division: Temerty Faculty of Medicine
Department: Dept of Medicine
Hospital Affiliation: UHN - Princess Margaret Hospital
Campus: St. George (Downtown Toronto)
Description:
The Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre, University Health Network (UHN) is seeking to recruit an energetic and innovative physician with expertise in malignant hematology; specifically with a keen interest in autologous stem cell transplantation, Lymphoma, Myeloma and/or Cellular Therapy to work within the Malignant Hematology Program. The successful applicant will have an academic position description of either Clinician Teacher, Clinician in Quality & Innovation, or Clinician Investigator. The successful applicant must be eligible for a Full Time Clinical Academic appointment at the rank of Assistant Professor or higher. The anticipated start date is October 1, 2025, or shortly thereafter.
The successful applicant will have a demonstrated passion for the medical care of cancer patients as well as a strong interest in teaching and/or quality improvement. The successful applicant will join a multidisciplinary team in the management of patients with hematological malignancies within a comprehensive cancer centre setting. In addition, the candidate will be expected to engage in clinical, translational, or basic research. Other responsibilities include teaching at the undergraduate and postgraduate levels.
Princess Margaret is home to one of the largest Hematology Programs across North America. Comprised of about forty senior physicians, the Malignant Hematology Program is supported by outstanding institutional infrastructure including hematopathology, cytogenetics and molecular diagnostics programs led by a wide medical and allied health multidisciplinary team. The program supports extensive clinical, translational, and basic research initiatives including a large clinical trials program. Additionally, the Division of Medical Oncology and Hematology supports a comprehensive training program attracting both national and international fellows.
Ranked in the top 10 on Newsweek’s list of the World’s Best Specialized Hospitals for Oncology, the Princess Margaret Cancer Centre includes the Princess Margaret Research Institute (formerly the Ontario Cancer Institute - OCI). This is a world-class basic and translational research institute with particular strengths in Genomics, Immunology, Stem Cell Biology, Cancer Biology, and Cell Therapeutics. The close association between clinicians and scientists provides the opportunity for collaborations on disease biology and the development of innovative and informative translational studies, allowing the applicant to achieve the goal of bench-to-bedside medicine. In addition, the Princess Margaret Cancer Centre supports active and widely recognized clinical trials and drug development programs and maintains a state-of-the-art GMP cell processing facility. Princess Margaret Cancer Centre is affiliated with the University of Toronto, which is world-recognized for programs in areas including Biochemistry, Immunology, Stem Cell Biology, Genomics, Proteomics, and Cell Processing, among others. Princess Margaret Cancer Centre is also a teaching hospital, dedicated to educating the world’s future top cancer experts. Our role as an internationally respected teaching hospital keeps us and our students abreast of the latest medical developments and the most advanced technology.
The successful candidate must be a Hematologist and be eligible for a full time clinical academic appointment at the rank of Assistant Professor or higher. It is expected that the candidate will be hired into one of the University of Toronto Clinician Investigator, Clinician Teacher, or Clinician Quality & Innovation tracks. For applicants being considered for appointment as a Clinician Teacher, excellence will be assessed by the presence of scholarly contributions to teaching and education as evidenced by pedagogical innovation, curriculum development, experience in teaching at the undergraduate and graduate level, and teaching awards. For Clinician Investigators, scholarly excellence will be assessed by the presence of research grants, publications in leading journals, invited presentations at significant conferences, awards, accolades, and other related accomplishments. The successful applicant must also hold a MD degree as well as specialist designation in Clinical Hematology or Medical Oncology, or equivalent. Each successful applicant must also have, or be eligible for both registration with the College of Physicians and Surgeons of Ontario and FRCPC qualifications. Academic rank, salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate. A highly attractive remuneration package is available.
Applications will be accepted until September 3, 2025, or until the position is filled. Should you be interested in this opportunity, please forward your covering letter, curriculum vitae, and the names and addresses of three referees to:
Dr. Natasha Leighl - Chief, Division of Medical Oncology and Hematology
c/o Michelle Williams, Business Manager
Princess Margaret Cancer Centre, University Health Network
Suite 7-925, 700 University Avenue, Toronto, Ontario, Canada, M5G 1Z5
Office: 416.946.2341
Fax: 416.946.2082 E-mail: michelle.williams@uhn.ca
CAUTION: This ad is “posted only” to the U of T affiliated hospital job board. Please see the information directly above for the application instructions; applications submitted via the "Apply Now" button on this page will NOT be considered for this position.
For more information on the Princess Margaret Cancer Centre and our world-recognized programs, visit: www.theprincessmargaret.ca
For more information about the Department of Medicine, please visit our website at: http://www.deptmedicine.utoronto.ca/
